Skip to main content
XTL Biopharmaceuticals Ltd. logo

XTL Biopharmaceuticals Ltd. — Investor Relations & Filings

Ticker · XTLB ISIN · IL0010854979 LEI · 529900NDDXEAPTUTXP41 TA Manufacturing
Open in API
Filings indexed 1,223 across all filing types
Latest filing 2008-06-11 Director's Dealing
Country IL Israel
Listing TA XTLB

About XTL Biopharmaceuticals Ltd.

https://www.xtlbio.com

XTL Biopharmaceuticals Ltd. is a clinical-stage biopharmaceutical company focused on the acquisition and development of pharmaceutical products to address unmet clinical needs. The company's primary therapeutic area of interest is autoimmune diseases. Its development pipeline has included proprietary drug candidates for conditions such as Systemic Lupus Erythematosus (SLE).

Recent filings

Filing Released Lang Actions
Director's Dealing 2008
Director's Dealing
2008-06-11 English
Director's Dealing 2008
Director's Dealing
2008-06-06 English
Board/Management Information 2008
Board/Management Information Classification · 95% confidence The document is a Form 6-K filed with the SEC by a foreign private issuer, XTL Biopharmaceuticals Ltd. The content announces the appointment of a new board member, Laurence N. Charney, to the company's Board of Directors. There is no financial data, earnings information, or detailed report content. The primary focus is on management/board changes. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document length is 6608 characters, which is sufficient for a detailed announcement but does not contain financial statements or other report types. Therefore, the correct classification is MANG with high confidence.
2008-05-28 English
Immediate Report
Board/Management Information Classification · 95% confidence The document is a press release announcing the appointment of Laurence N. Charney to the company's Board of Directors. It focuses on management changes and does not contain financial statements, audit information, or regulatory filings. The content is about a change in senior management, specifically a board member appointment, which fits the category of Board/Management Information (MANG). The document length is 4490 characters, which is sufficient for a detailed announcement but does not indicate a full report or regulatory filing. There is no indication that this is a report publication announcement or a certification. Therefore, the appropriate classification is MANG with high confidence.
2008-05-28 Hebrew (modern)
Immediate Report
Board/Management Information Classification · 98% confidence The document is an 'Immediate Report' filed under Israeli regulations (Regulation 4 of the Securities Regulations). The key content explicitly states: 'Attached hereto is a report on *Company Announces Appointment of Laurence N. Charney to Board of Directors*'. This indicates the document itself is an announcement regarding a change in the board of directors, not the detailed report itself. According to the definitions, announcements of changes in the company's board of directors or senior management map directly to the 'Board/Management Information' category (MANG). The document length is short (1646 chars), supporting the conclusion that it is an announcement (RPA/RNS) rather than the full report, and MANG is more specific than RNS.
2008-05-28 English
Investor Presentation 2008
Investor Presentation Classification · 90% confidence The document is a Form 6-K filed with the SEC by a foreign private issuer, XTL Biopharmaceuticals Ltd. It announces that the CEO will present at a healthcare conference and provides details about the presentation and webcast. The document is short (3242 characters) and primarily serves as an announcement of an upcoming investor presentation event rather than the presentation itself or detailed financial data. It does not contain financial statements or substantive financial analysis. Therefore, it fits best as an Investor Presentation announcement. Given the nature of the content, the most appropriate classification is Investor Presentation (IP).
2008-05-15 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.